Astrana Health, Inc. (NASDAQ:ASTH – Get Free Report)’s share price rose 3.3% on Wednesday . The company traded as high as $39.48 and last traded at $39.14. Approximately 2,798 shares changed hands during trading, a decline of 98% from the average daily volume of 160,858 shares. The stock had previously closed at $37.89.
Analyst Upgrades and Downgrades
Several analysts have recently commented on the company. Jefferies Financial Group assumed coverage on Astrana Health in a report on Monday, February 26th. They issued a “buy” rating and a $50.00 price target for the company. Truist Financial raised their price target on Astrana Health from $41.00 to $44.00 and gave the company a “hold” rating in a report on Friday, March 1st.
Read Our Latest Stock Analysis on ASTH
Astrana Health Stock Down 0.9 %
Astrana Health (NASDAQ:ASTH – Get Free Report) last released its quarterly earnings data on Tuesday, February 27th. The company reported $0.26 earnings per share for the quarter, beating the consensus estimate of $0.17 by $0.09. Astrana Health had a return on equity of 11.52% and a net margin of 4.49%. The firm had revenue of $353.00 million during the quarter, compared to the consensus estimate of $341.17 million. During the same period last year, the business posted $0.02 EPS. Astrana Health’s quarterly revenue was up 20.0% on a year-over-year basis. Sell-side analysts anticipate that Astrana Health, Inc. will post 1.62 earnings per share for the current fiscal year.
Astrana Health Company Profile
Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.
Read More
- Five stocks we like better than Astrana Health
- What is Put Option Volume?
- Comprehensive PepsiCo Stock Analysis
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- CSX Co.: The Railroad Powering Ahead with an Earnings Beat
- Stock Trading Terms – Stock Terms Every Investor Needs to Know
- Bear Market Funds to Watch This Year
Receive News & Ratings for Astrana Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Astrana Health and related companies with MarketBeat.com's FREE daily email newsletter.